Lactobacillus crispatus LV5 and Absence of Adverse Effects

• Safety, tolerability, and acceptability of Lactobacillus crispatus CTV-05 (LACTIN-V) in pregnant women at high-risk of preterm birth.

  • 2023-02-23
  • Clinical Trial · n = 73
  • Beneficial Microbes 14(1)
  • • E. Bayar
    • D. MacIntyre
    • L. Sykes
    • K. Mountain
    • T. Parks
    • P. Lee
    • P. Bennett

  • PubMed: 36815494
  • DOI: 10.3920/BM2022.0084

  13 Insights on

  • Absence of Adverse Effects

  • High evidence

  No serious adverse events occurred.

  • Beneficial
  • Large effect